UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.


Patrick Lindsay, President, UBC
UBC - September 21, 2016
UBC President Patrick Lindsay began his career in the biopharma industry as a data manager working on a 280,000-patient breast cancer research study that helped define mammography screening guidelines. In the 30 years since then, he’s...
Nurses drive improved adherence
UBC - September 15, 2016
Reimbursement challenges can cause lengthy delays in therapy initiation for patients with life-threating diseases. However, improving outcomes is more than just overcoming barriers to access. Many patients, already at an increased...
Catherine Sigler, PhD, Executive Director, Safety, Epidemiology, Registries, and Risk Management (SERRM) - September 14, 2016
UBC’s distinguished scientists recently participated in the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Dublin. The team presented abstracts and attended a variety of sessions. Here were...
Patient recruitment - social media and texting
Amelia Kerin, Patient & Physician Services - September 13, 2016
With summer behind us, many of our clients are focused on year-end milestones. Maybe it’s first patient randomized in a new study or meeting the study enrollment goal or a target number of sites activated. If you’ve been reading our...
Patient centricity in clinical trials
UBC - September 08, 2016
This year may go down as “the year of the patient” thanks to the explosion of discussion around patient-centric design – both in clinical studies and commercial support programs. Sponsors and CROs are embracing the opportunity to...